This inventor holds 14 USPTO granted patents, plus 2 CIPO patents. Top assignees: Zymogenetics, Inc., Novo Nordisk A/s. Active years: 1994-2001.
Company Filing History:
Years Active: 1994-2001
Title: The Innovations of James R Piggott
Introduction
James R Piggott is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various bone and skin conditions. With a total of 14 patents to his name, Piggott's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents, Piggott has developed piperazine derivatives that are useful in treating osteoporosis, bone fractures, and other bone-related deficiencies. These compounds are designed to address conditions such as primary or secondary hyperparathyroidism, periodontal disease, metastatic bone disorders, and osteolytic bone disease. Additionally, he has worked on novel uses of compounds aimed at treating atrophy of skin and mucous membranes, providing new avenues for pharmaceutical compositions in this area.
Career Highlights
Throughout his career, Piggott has been associated with prominent companies such as Zymogenetics, Inc. and Novo Nordisk A/S. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.
Collaborations
Piggott has worked alongside notable colleagues, including Virender M Labroo and Robert A Smith. Their combined expertise has fostered innovation and advancement in the pharmaceutical industry.
Conclusion
James R Piggott's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of treatments for critical health conditions.